. 2011 Apr 1;44(3):907–919. doi: 10.1007/s11255-011-9947-4

Table 5.

Statistically significant correlations found in haemodialysed patients

	Tf3
Duration of HD treatment	r = −0.41 P = 0.04	r = −0.43 P = 0.033
eGFR	r = 0.88 P = 0.0001	r = 0.55 P = 0.004
RBC	r = 0.57 P = 0.003	r = 0.55 P = 0.004
HGB	r = 0.4 P = 0.004	r = 0.88 P = 0.0001
Fe	r = 0.55 P = 0.004	r = 0.58 P = 0.002
hsCRP	r = −0.46 P = 0.019	r = −0.047 P = 0.021
IL-6	r = −0.176 P = 0.041	r = −0.186 P = 0.029

Tf3

mHD1

mHD2

Duration of HD treatment

r = −0.41

P = 0.04

r = −0.43

P = 0.033

eGFR

r = 0.88

P = 0.0001

r = 0.55

P = 0.004

RBC

r = 0.57

P = 0.003

r = 0.55

P = 0.004

HGB

r = 0.4

P = 0.004

r = 0.88

P = 0.0001

r = 0.55

P = 0.004

r = 0.58

P = 0.002

hsCRP

r = −0.46

P = 0.019

r = −0.047

P = 0.021

IL-6

r = −0.176

P = 0.041

r = −0.186

P = 0.029

mHD1—patients at the beginning of study and mHD2—patients after 1 year of the study

To calculate the correlations—Spearman’s rank correlation coefficient was used

Tf3 variant of transferrin, HD haemodialysis, eGFR estimated glomerular filtration rate, RBC red blood cells, HGB haemoglobin, Fe serum iron, hsCRP high sensitivity C-reactive protein, IL-6 interleukin 6

Significant correlation when P < 0.05